SCHIZOAFFECTIVE DISORDER
Clinical trials for SCHIZOAFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOAFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOAFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Study links mental health drugs to heart Risk—Tests solutions
Disease control TerminatedThis study looked at whether certain medications for schizophrenia and bipolar disorder increase the risk of heart disease. Researchers measured cholesterol levels and heart activity in 48 participants already taking these medications. They then tested whether changing medication…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Eye scan could reveal best drug for schizophrenia
Disease control TerminatedThis study tested whether a non-invasive scan of the eye's blood vessels could predict which patients with early schizophrenia would respond to an intravenous drug called sodium nitroprusside. The drug was given to help reduce symptoms of psychosis and improve thinking. The goal …
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Online hub tested to help young adults with psychosis feel less alone
Knowledge-focused TerminatedThis study looked at how well a digital platform called Horyzons could be added to regular mental health care. Horyzons offers therapy content and a private social network. Researchers worked with clinics in North Carolina to understand what helps or hinders using the platform. T…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC